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Neurotensin and cholecystokinin contract gallbladder
circular muscle in chickens
T. F. DeGolier,*1 D. R. Brown,† G. E. Duke,†2 M. M. Palmer,* J. R. Swenson,* and R. E. Carraway‡
*Department of Biological Sciences, Bethel University, 3900 Bethel Drive, St. Paul, MN 55112;
†Department of Veterinary and Biomedical Sciences, University of Minnesota, St. Paul 55108;
and ‡Department of Physiology, University of Massachusetts, Worcester 01605
ABSTRACT The contractile effects of neurotensin
(NT) and cholecystokinin octapeptide (CCK-8) on
isolated circular smooth muscle strips of chicken gallbladder were investigated. The NT (0.25–300 nM) produced concentration-dependent contractions on smooth
muscle with an EC50 of 8.5 nM (95% confidence limits = 5.3–13.6 nM). In comparison, CCK-8 produced
concentration-dependent contractions with an EC50
of 13 nM (95% confidence limits of 9–20 nM). There
were no statistical differences in contractile responses
when comparing NT and CCK-8 at equimolar concentrations. The NT appears to act directly on smooth
muscle tissue in the chicken; the contractile responses
were not blocked by 10 μM atropine or tetrodotoxin.

A portion of the activity is mediated by extracellular
calcium as 100 nM nifedipine inhibited 30% of peptideinduced muscle tension. The NT receptor (NTR) type
1 antagonist SR 48692 (0.1 μM) did not significantly
reduce NT potency. The contractile effects of CCK-8
remained unaltered in tissues pretreated with atropine,
TTX, or nifedipine. The CCK-A antagonist lorglumide,
at a concentration of 1 μM, reduced the contractile
potency of CCK-8 by one-half. Avian receptors for
NT and CCK may differ pharmacologically from their
mammalian counterparts, but their contractile actions
on the gallbladder resulting in increased biliary output
by flow are further evidence of their role in the postprandial regulation of lipid digestion in chickens.
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INTRODUCTION
The most effective hormonal stimulant of gallbladder evacuation in mammals is cholecystokinin (CCK).
Indeed, both contraction and relaxation of the gallbladder correlate well with plasma concentrations of
the peptide (Wiener et al., 1981). Nevertheless, several
other gut hormones influence the postprandial regulation of smooth muscle tension in the gallbladder. For
example, the effects of CCK on guinea pig gallbladder
are augmented by secretin and glucagon that by themselves have no contractile activity. Even though secretin and glucagon are structurally related to vasoactive
intestinal polypeptide (VIP), contractions induced by
CCK are decreased in the presence of VIP (Vagne and
Troistkaja, 1976). Similarly, VIP antagonizes the effects of CCK on gallbladder pressure in the opossum
and by itself induces dose-related decreases in basal
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gallbladder pressure (Ryan and Cohen, 1977). Gastrin
has been shown to have only weak cholecystokinetic
activity (Vagne and Grossman, 1968). In muscle strips
from human gallbladder tissue, motilin produced contractions, whereas pancreatic polypeptide induced gallbladder relaxation and inhibited biliary output (Greenberg et al., 1978; Pomerantz et al., 1983).
Neurotensin (NT) is a biologically active tridecapeptide occurring in the central nervous system and the
gastrointestinal (GI) tract of several species. It was
originally isolated from extracts of bovine hypothalami
(Carraway and Leeman, 1973) and the GI tract (Kitabgi et al., 1976; Carraway and Leeman, 1976b). The majority of the total NT content is found in the intestinal
tract (Carraway and Leeman, 1976b; Carraway et al.,
1982). The amino acid sequence is identical from both
tissue sources: pGlu-Leu-Tyr-Glu-Asn-Lys-Pro-ArgArg-Pro-Tyr-Ile-Leu-OH (Carraway and Leeman, 1975,
1976a). The presence of NT has been immunochemically identified in brain and gut tissue samples from
all representative vertebrate classes (including birds)
and some invertebrates (Carraway et al., 1982). In all
species examined, the biologically active carboxyl-terminus of the peptide is highly conserved.
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Neurotensin is expressed in higher concentrations in
the avian gut than in the mammalian gut (Carraway et
al., 1982). Enteroendocrine N-type cells, which release
NT into the circulation, are diffusely distributed along
the entire intestinal tract of chickens and are particularly numerous in the pylorus, the zone that adjoins
the gizzard (Sundler et al., 1977). In contrast, most of
the N cells in mammalian intestine are present chiefly
in the jejunum and ileum, and are very sparse in the
duodenum (Orci et al., 1976; Helmstaedter et al., 1977;
Polak et al., 1977; Sundler et al., 1977).
The actions of avian intestinal NT indicate a role in
the regulation of fat digestion in chickens. Neurotensin
inhibits gastric motility and pepsin secretion (DeGolier
et al., 1997), increases pancreatic lipase activity (DeGolier et al., 1999), and increases bile acid production
and secretion (Gui et al., 2000). As in mammalian species (Kalafatakis and Triantafyllou, 2011), oleic acid
has been shown to be a potent stimulus for the release
of NT (DeGolier et al., 2013).
To support the observation that NT acts like an enterogastrone, the potential cholecystogogue activity of
NT warrants investigation. Thus, the objectives of this
study were to 1) observe and quantify the contractile
effects of NT on the smooth muscle contraction of the
gallbladder (in vitro), 2) compare those contractile effects to those of the most effective hormonal stimulant
of gallbladder evacuation, CCK, and 3) to investigate
potential mechanisms underlying NT and CCK contractile activity in chickens.

MATERIALS AND METHODS
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cally (Hodges, 1974). The left hepatic duct drains bile
directly from the liver into the duodenum, and the right
hepatic duct drains bile into a gallbladder for storage
between meals. In chickens, the gallbladder is a pearshaped sac, 2 to 5 cm in length, and lies with its blind
end opposite the caudal edge of the liver. When the
gallbladder contracts, bile is forced into the cystic duct,
which empties into the duodenum distal to the insertions of the left hepatic duct and the pancreatic ducts.

Tissue Preparation
Chickens were fasted overnight to ensure that plasma
NT and CCK concentrations were basal. At the beginning of each experiment, the birds were euthanized by
cervical dislocation, and gallbladders were removed and
placed immediately in ice-cold Tyrode’s buffer, which
was continuously gassed with 5% CO2 in 95% O2. Strips
of circular smooth muscle (2 mm × 10 mm) were tied
at the ends with surgical thread and suspended isometrically in isolated organ tissue baths maintained at
38°C and bubbled under a resting tension of 1.96 mN.
Buffer was changed every 15 min for 1 h before experiments began. At the beginning of each experiment, 10
µM carbachol was added to test the reactivity of the
preparations. Discrete concentration-response tests using 0.25, 0.5, 1.0, 1.5, 2, 5, 10, 30, 50, 100, and 300 nM
peptide were performed at 10-min intervals separated
by multiple washes in between. Contractions were recorded via force transducers that were connected to a
4-channel polygraph (model 79-D, Grass Instruments,
Quincy, MA).

Birds

Drugs and Peptides

Single-Comb White Leghorn hens, 14–22 wk of age,
were used in this study. Body weights ranged from 0.8
to 1.4 kg. The hens were housed in individual wire cages in environmentally controlled rooms maintained at
25°C. Relative humidity was kept between 40 and 50%,
and photoperiod was controlled to provide 14 h of light
from 0900 to 2300 h. All birds had access to water and
a diet (all mash breeder ration: 16% protein, 4.5% CP,
3% crude fat, and 2,874 kcal/kg of ME) ad libitum
prepared by the Department of Animal Sciences at the
University of Minnesota. All procedures were in accordance with the policies of the University of Minnesota
Institutional Animal Care and Use Committee.

Avian NT has been isolated from the intestine of
chickens and has a sequence similar to bovine NT (Carraway and Leeman, 1973) except for the substitution
of His3, Val4, and Ala7 for Tyr3, Glu4, and Pro7 (Carraway and Bhatnagar, 1980). The biologically active
carboxy-terminus of the peptide is common to both
species. Anesthetized rats given chicken NT (0.5 nmol/
mL per kg) exhibited similar physiological effects to
those induced by bovine NT [i.e., hypotension, hyperglycemia, and cyanosis (Carraway and Bhatnagar,
1980)]. Chicken NT also produced the same effects
as bovine NT when applied to chicken rectal smooth
muscle (Komori et al., 1986). Therefore, bovine NT
was used because it is commercially available and was
purchased from Peninsula Laboratories (Belmont, CA).
Neurotensin was solubilized in 0.1% BSA in 0.01 M
acetic acid. The nonpeptide antagonist of the NTR1
antagonist, SR 48692, was obtained gratis from Sanofi
Rechereche (Toulouse Cedex, France) and was solubilized in dimethyl sulfoxide.
Cholecystokinin octapeptide (CCK-8) was also purchased from Peninsula Laboratories and solubilized in
distilled water containing a few drops of dilute acetic

Chicken Gallbladder
The longitudinal and circular muscle layers of chicken
gallbladder are not easily distinguished, as the arrangement appears to vary with the degree of distention. The
outer circular layer is the more defined layer, whereas
the longitudinal layer is less obvious (Hodges, 1974).
Unlike mammals, which have a single bile duct,
chickens have 2 ducts that are connected intrahepati-
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analyzed with a computer software program designed
by Tallarida and Murray (1981).

RESULTS
Effect of NT on Gallbladder Contraction
and Receptor Antagonism

Figure 1. Contractile actions of neurotensin and cholecystokinin
(CCK-8) on smooth muscle from chicken gallbladders oriented in the
circular plane. Each point represents the mean contractile amplitude
± SEM at the given concentrations. Data represent 21 tissues from 9
different birds.

acid. The CCK-A antagonist lorglumide was purchased
from Research Biochemicals Inc. (Sigma-RBI, Natick,
ME) and dissolved in dilute methanol.
The cholinergic agonist carbachol (CCH) and the
muscarinic cholinergic antagonist atropine sulfate were
purchased from Peninsula Laboratories and dissolved
in distilled water. Veratrine, a neuronal sodium channel
activator, and tetrodotoxin (TTX), a selective axonal
sodium channel blocker, were solubilized in methanol
and ethanol, respectively. Nifedipine, a calcium channel blocker, was solubilized in dimethyl sulfoxide and
experiments using it were conducted under low light
conditions. These drugs were purchased from SigmaAldrich (St. Louis, MO).

Statistical Comparisons
Changes in contractile force (in mN) were observed
and were determined from the baseline to the top of
the treatment-induced response. Contractile responses
were measured and means ± SEM were calculated for
each concentration. Differences in responses among
varying doses were statistically analyzed using ANOVA
for multiple comparisons among means. Following the
rejection of the null hypotheses that neither NT nor
CCK-8 had any contractile effect on isolated strips of
gallbladder, the Tukey-Kramer honestly significant difference test (JMP software, 2001, SAS Institute Inc.,
Cary, NC) was used to determine which of the concentration responses were significantly different from each
other. Additional concentration response data were

Neurotensin (0.25–300 nM) induced concentrationdependent contractions on the circular smooth muscle
of the gallbladder (Figure 1) with an EC50 of 8.5 nM
(95% confidence limits = 5.3–13.6 nM). The contractile
effects of NT remained unaltered in tissues pretreated
with10 µM atropine (P < 0.01, n = 3). Nevertheless,
the effects of the cholinergic agonist carbachol were
prevented by atropine at this concentration. Veratrine
produced small changes in muscle tension that were inhibited by 0.1 µM TTX. The neurotoxin failed to alter
the contractile actions of NT. The contractile response
to NT was partially reduced by 0.1 µM nifedipine (69%
of untreated tissues, P < 0.05, n = 4). The NTR1 antagonist SR 48692 (0.1 µM) did not produce a significant reduction in NT potency (Figure 2a).

Effect of CCK-8 on Gallbladder Contraction
and Receptor Antagonism
Cholecystokinin octapeptide (0.25–300 nM) also induced concentration-dependent contractions on the circular smooth muscle of the gallbladder (Figure 1) with
an EC50 of 13 nM (95% confidence limits of 9–20 nM).
The contractile effects of CCK-8 remained unaltered in
tissues pretreated with atropine, TTX, or nifedipine.
The CCK-A antagonist, lorglumide, at a concentration
of 1 µM, reduced the contractile potency of CCK-8 by
one-half (Figure 2b).

Comparing NT Contractile Responses
to CCK-8
There were no statistical differences in contractile responses when comparing NT and CCK-8 at equimolar
concentrations. Two additional gallbladder strips were
used to determine if NT or CCK (at 10, 20, and 30 nM
concentrations) had any potentiating or attenuating effect on each other after 2 min of incubation. In both
cases, CCK-8 never elicited a contractile effect following a maximal contractile response to NT. However,
NT always produced a contractile effect after a maximal contractile response to CCK-8.

DISCUSSION
The results of this study demonstrate that both NT
and CCK-8 contract isolated circular smooth muscle
of the gallbladder in vitro. Increased intestinal bile
availability, as a result of increased bile flow, enhances
the digestion and absorption of lipids in the intestine.

NEUROTENSIN CONTRACTS CHICKEN GALLBLADDER IN VITRO

Figure 2. (a) The effect of neurotensin (NT) on the isolated circular smooth muscle of the chicken gallbladder in the absence and presence of SR 48692. The maximal contraction produced by NT in the
absence of the antagonist was 2.45 ± 0.2 mN. Each point represents
the mean ± SEM of the percentage of maximal contraction to peptide
alone determined in 11 tissues obtained from 4 birds. (b) The effect
of cholecystokinin (CCK-8) on the isolated circular smooth muscle of
the chicken gallbladder in the absence and presence of lorglumide. The
maximal contraction produced by CCK-8 in the absence of the antagonist was 3.33 ± 0.59 mN. Each point represents the mean ± SEM of
the percentage of maximal contraction to peptide alone determined in
11 tissues obtained from 4 birds.
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Bile acids, the major component of bile, are capable
of emulsifying lipids, resulting in more surface area for
lipolytic enzyme activity. Bile acids can also form micelles with the products of lipid digestion and enhance
fat transport and absorption across the brush-border of
the intestine.
Neurotensin and CCK are both brain-gut peptides
and they bind to different receptor types based on the
selectivity of their ligands. Three subtypes of NT receptors have been cloned and functionally characterized.
The NTR1 are expressed in brain and intestinal tissues
and have a higher affinity for NT than the NTR2 localized primarily in brain tissue (Kitabgi et al., 1985). The
NTR3 is distributed in the brain and non-GI peripheral tissues (Vincent et al., 1999). The NTR1 regulates
gut motility and secretion (Vincent, 1995). The CCK
receptors have been broadly classified as CCKA (for
alimentary) receptors and CCKB (for brain) receptors
(Dourish and Hill, 1987), although both receptors are
expressed in various tissues of the central nervous system and the GI tract (Wank, 1995).
To evaluate the actions of NT and CCK-8 on gallbladder contraction in chickens, we attempted to antagonize the specific actions of NT and CCK-8 at their
cognate receptors and thus lessen or abolish their biological effects. The NTR1 antagonist SR 48692 (Gully
et al., 1993) has been shown to inhibit NT binding to
cloned rat and human NT receptors and antagonize
NT-induced turning behavior in mice. Moreover, it inhibited hepatic bile flow in chickens (Gui et al., 2000).
On the other hand, SR 48692 failed to antagonize NTinduced hypothermic effects in rat and mice (Dubuc
et al., 1994), and at a concentration of 0.1 µM, we
were unable to demonstrate a significant reduction in
NT contractile potency in the present study (Figure
2b). Chicken NTR1 has a high sequence identity with
its amphibian and mammalian counterparts (Numao
et al., 2011). We hypothesize that NT contractile effects in the chicken gallbladder that are resistant to SR
48692 may be mediated by an unconventional receptor pharmacologically distinct from NTR1, possibly the
avian equivalent of NTR2 or NTR3 (Dubuc et al., 1994;
Mazella and Vincent, 2006).
Other studies of CCK on poultry have also demonstrated that mammalian-derived antagonists are ineffective in blocking CCK activity in avian preparations.
For example, the CCK-8 actions on gastroduodenal
motility and coordination in chickens could not be inhibited by either CCK-A receptor antagonist, L364,718,
or CCK-B receptor antagonist, L365,260 (Martinez et
al., 1993). Pancreatic secretion induced in turkeys was
also not blocked by the CCK-A receptor antagonist
L364,718 (Campbell et al., 1991). In contrast, CCK-8
induced suppression of food intake in white-crowned
sparrows was inhibited by the CCKA receptor antagonist MK-329 (Richardson et al., 1993).
Although the CCK-A antagonist lorglumide in our
study did produce an increase in the EC50 value for
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CCK-8 (Figure 2b), the effect was small in comparison
with that observed in mammalian studies. Increasing
doses of lorglumide (0.2–6.5 µM) caused a rightward
shift of the dose response curve for CCK-8 from an
EC50 of 8.2 nM ± 1.62 to an EC50 of 100 nM ± 12
in guinea pig gallbladder strips and a shift from an
EC50 of 47 nM ± 8 to an EC50 of 300 nM ± 10 in human gallbladder strips (Portincasa et al., 1990). This
phenomenon may be attributable to known pharmacological differences between avian and mammalian CCK
receptors (Rodríguez-Sinovas et al., 1995).
At equimolar concentrations, NT and CCK-8 evoked
contractions in the chicken gallbladder isolated strips
that were equivalent in magnitude. However, research
with mammalian tissues has shown that NT and CCK
actions on gallbladder contractions are species-specific.
In canine gallbladder strips, the contractile responses
to NT were less sensitive than those to CCK (Milenov
et al., 1993), possibly affirming a greater presence of
CCK receptors in chicken gallbladder tissue. Neurotensin was ineffective in contracting rabbit gallbladder
muscle strips (Guo et al., 1989) even though CCK-8
produced concentration-dependent contractions (Amer,
1972). In isolated gallbladder strips from guinea pigs,
NT induced concentration-dependent contractions
(Guo et al., 1989; Milenov et al., 1993). In similar studies, the NT-induced responses were reduced by tetrodotoxin (TTX) and atropine, and reversed by indomethacin, suggesting that some contractile activity may be
via prostaglandin synthesis (Yamasato and Nakayama,
1988). Neurotensin also induced concentration-dependent contractions in canine gallbladder strips. These
responses were not modified by TTX, indicating that
NT mediates at least some of its contractile effects by
directly acting on smooth muscle (Guo et al., 1989).
No contraction or relaxation was observed in human
isolated gallbladder strips (Guo et al., 1989).
The mechanisms whereby NT and CCK evoke their
gallbladder contractile actions may depend on whether
data are collected from isolated tissues or intact organisms. In vivo studies using strain gauge force transducers to monitor canine contractile activity following bolus injections of NT or CCK (equivalent to endogenous
release) showed the resulting gallbladder contractions
to be very similar. In contrast to some in vitro studies, cholinergic pathways likely mediate these responses
because both were abolished by atropine (Fujimura
et al., 1994). Work by Milenov et al. (1993) also observed similar results when conscious dogs were given
NT and CCK-8 intravenously. Both NT and CCK-8
induced gallbladder pressures that were increased in
a dose-dependent manner were inhibited by atropine
or hexamethonium. In contrast, Walker et al. (1985),
using ultrasonography in humans, reported that sustained infusion of NT produced a gradual, steady dilatation of the gallbladder.
It can be postulated that NT functions in concert
with CCK to promote the digestion and absorption of

lipids. Cholecystokinin is a 33 amino acid brain-gut
peptide (Thorpes and Mutt, 1973; Dockray, 1976; Rehfeld et al., 1979). Intestinal CCK is produced by open
enteroendocrine I cells of the proximal intestine (Buffa
et al., 1976), and its primary stimulus for release is
also the presence of long-chain fatty acids, as well as
amino acids (Meyer, 1975). Cholecystokinin activity in
vertebrate digestion is well documented; in addition to
being a potent contractor of the gallbladder (Ivy and
Oldberg, 1928; Schjoldager, 1994), CCK is a stimulus
for pancreatic activity (Harper and Raper, 1943) and
has been shown to mediate relaxation of the stomach,
resulting in a delay in gastric emptying in humans
(Raybould and Tache, 1988; Liddle et al., 1989; Fried
et al., 1991; Young et al., 1996; Schwizer et al., 1997).
In conclusion, NT contracts the isolated circular
smooth muscle of the gallbladder as effectively at CCK8. Our results clearly indicate that avian receptors for
NT and CCK-8 differ in their ability to bind antagonists in comparison with their mammalian counterparts. Neither SR 48692 nor lorglumide completely antagonized the action of NT or CCK-8, respectively, on
the gallbladder. Thus, the actions of the 2 peptides are
mediated through avian receptors that may differ pharmacologically from their mammalian counterparts and
are differentially dependent upon extracellular Ca2+.
As with NT- and CCK-induced gallbladder contractions in mammalian models, NT and CCK may have a
common physiological role in the postprandial regulation of lipid digestion in chickens.
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